About Pricing FAQs Providers Trials Blog

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? [email protected]

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

AI Models for Predicting Occult Pleural Dissemination in NSCLC

NCT07065422·1 site·ClinicalTrials.gov

What this study is about

Take this into the appointment.

Saves the questions and what to expect into your notes, next to the visit they belong to.

Keep this study

Lead

Daping Hospital and the Research Institute of Surgery of the Third Military Medical University

With

First Affiliated Hospital of Chongqing Medical University
Xinqiao hospital of the third military medical university

Age

Any age

Sex

ALL

Healthy volunteers

Not accepted

You may be eligible if

pathologically confirmed primary NSCLC with malignant pleural dissemination;
no preoperative treatment;
clinicopathological data were complete.

You may not be if

pleural effusion detected preoperatively;
preoperatively diagnosed with PD;
poor CT quality or no CT scans within 1 month before surgery.

The record

StatusCompleted

PhaseNo phase

Taking part326

StartedDec 2023

UpdatedAug 6, 2025

Conditions

Non-Small Cell Lung Cancer

Where1

Daping hospital
Chongqing, China

Clareo Health | AI Models for Predicting Occult Pleural Dissemination in NSCLC